ArticleScience advances2025
Molecularly tailored dual-interface passivation via solvent-free rub-on transfer for efficient and stable perovskite LEDs.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Charge-Carrier Behavior and Molecular Interface Engineering in Perovskite Light-Emitting Diodes.Nano-micro letters · 2026Review
- Perovskite Light-Emitting Diodes: Engineering, Stability, and Applications.Micromachines · 2026Review
- Synergistic Dual-Passivation of Grain Boundaries and Buried Interface for High-Efficiency and Stable Perovskite Solar Cells.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional solution-based passivation methods for perovskite light-emitting diodes (PeLEDs) often introduce secondary defects. A molecularly tailored dual-interface passivation strategy is presented using a solvent-free rub-on transfer method, which enables uniform molecular deposition without inducing secondary defects. Specifically, 4-mercaptopyridine (4-MPy) is applied at the buried interface, and 2-mercaptopyridine (2-MPy) is applied on the perovskite surface. At the buried interface, 4-MPy stabilizes Ni
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.